Inactivation of Terminal Oxidase bd-I Leads to Supersensitivity of E. coli to Quinolone and Beta-Lactam Antibiotics
In cells of Escherichia coli , terminal oxidase bd-I encoded by the cydAB gene catalyzes the reduction of O 2 to water using hydroquinone as an electron donor. In addition to the cydAB operon, two other genes, cydC and cydD , encoding the heterodimeric ATP-binding cassette-type transporter are essen...
Saved in:
Published in | Molecular biology (New York) Vol. 56; no. 4; pp. 572 - 579 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Moscow
Pleiades Publishing
01.08.2022
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In cells of
Escherichia
coli
, terminal oxidase bd-I encoded by the
cydAB
gene catalyzes the reduction of O
2
to water using hydroquinone as an electron donor. In addition to the
cydAB
operon, two other genes,
cydC
and
cydD
, encoding the heterodimeric ATP-binding cassette-type transporter are essential for the assembly of cytochrome bd-I. It was shown that inactivation of cytochrome bd-I by the introduction of
cydB
or
cydD
deletions into the
E. coli
chromosome leads to supersensitivity of the bacteria to antibiotics of the quinolone and beta-lactam classes. The sensitivity of these mutants to antibiotics is partially suppressed by introduction of a constitutively expressed gene
katG
under the control of the P
tet
promoter into their genome. The increased level of hydrogen sulfide resulting from the introduction of the
mstA
gene, encoding 3-mercaptopyruvate sulfurtransferase, under the control of the P
tet
promoter, leads to the same effect. These data demonstrate the important role of cytochrome bd-I in the defense of bacteria from oxidative stress and bactericidal antibiotics. |
---|---|
ISSN: | 0026-8933 1608-3245 |
DOI: | 10.1134/S0026893322040100 |